Pharma distribution directory 2026

    Pharmaceutical Distributors in Iraq

    Iraq is a 45-million-person market supplied through two parallel systems: the federal state importer KIMADIA, which buys for Ministry of Health hospitals, and a private network of licensed scientific bureaus and drug stores that register foreign brands and sell them to the private pharmacies where most Iraqis actually buy their medicines.

    The Kurdistan Region adds a third layer with its own Ministry of Health, its own registration track and its own distributors based in Erbil and Sulaymaniyah. Foreign manufacturers therefore appoint a Baghdad scientific bureau for federal registration and often a separate Kurdish partner for the north. The directory below lists the state buyers, the domestic manufacturers that supply tenders, the leading private distributors and the regional pharmaceutical groups that market through Iraqi bureaus, arranged so that a brand team can see how product reaches Baghdad, Basra, Mosul and Erbil.

    Updated September 2026 · Iraq Ministry of Health — KIMADIA supplier registration and licensed scientific bureaus as of September 2026 · 13 named accounts

    Request a proposal for IraqBrowse the 13 companies

    $2.5bn+

    Iraqi pharmaceutical market, 2024 estimate

    ~65%

    Share of spend paid out-of-pocket through private pharmacies

    2

    Registration tracks (federal MOH and Kurdistan Region MOH)

    ~15,000

    Licensed private pharmacies

    Named accounts

    Top pharmaceutical distributors in Iraq

    Public, well-known names BioNixus studies at account and SKU level. This is an editorial snapshot, not an endorsement or a market-share ranking. Cross-checked against Iraq Ministry of Health — KIMADIA supplier registration and licensed scientific bureaus (as of 2026-09-03).
    #CompanyHQ
    01KIMADIA (State Company for Marketing Drugs and Medical Appliances)Baghdad
    02KRG Ministry of Health — Directorate of Medical SuppliesErbil
    03Samarra Drug Industries (SDI)Samarra
    04Pioneer Co. for Pharmaceutical IndustriesSulaymaniyah
    05Awamedica (Awa Group)Erbil
    06Al Mansour Pharmaceutical IndustriesBaghdad
    07Modern Drug Industries (MDI)Baghdad
    08Zozik GroupErbil
    09MS Pharma (Iraq)Amman
    10Hikma Pharmaceuticals (Iraq operations)Amman
    11Julphar (Iraq)Ras Al Khaimah
    12DHL Global Forwarding IraqBaghdad
    13Aramex IraqBaghdad

    Primary research

    These are the distributors and wholesalers we map in Iraq

    Choosing or auditing a distribution partner in Iraq? BioNixus runs distributor due-diligence interviews, channel-share estimates and pharmacy-level availability checks. Proposal ready within 48 hours of a brief.

    Planning research in Iraq?

    Primary research, market access & HEOR. A 30-minute scoping call, then a costed proposal within 48 hours.

    What happens on the call

    • We pin down the decision your research has to support.
    • We check feasibility: respondent types, countries and timeline.
    • You receive a costed proposal within 48 hours of the call.

    Top market research companies in Iraq (2026)

    How the market is structured

    How pharmaceutical distribution works in Iraq

    The public channel begins with KIMADIA, the State Company for Marketing Drugs and Medical Appliances, which registers suppliers, issues tenders for Ministry of Health hospitals and primary-care centres, imports awarded products and distributes them to governorate warehouses. Tender payment delays and formulary gaps mean public facilities frequently run short, pushing patients into the private market. In that private channel, a foreign brand is registered at the MOH by a licensed scientific bureau, which imports through Basra, Baghdad International Airport or the Turkish and Jordanian land borders and sells on to wholesalers in the Shorja and Bab Al-Muadham drug markets and to private hospitals, before product reaches around 15,000 pharmacies. The Kurdistan Region operates separately: the KRG Ministry of Health registers products, Erbil-based groups such as Zozik distribute, and cross-border flows from Turkey and Iran are significant. Domestic manufacturers, led by Samarra Drug Industries in the state sector and Pioneer, Awamedica, Al Mansour and Modern Drug Industries in the private sector, supply KIMADIA tenders with local-preference status and increasingly compete in retail. Cold chain remains the weakest link, with validated storage concentrated in Baghdad and Erbil.

    Local

    Iraqi scientific bureaus, drug stores and private manufacturers that register brands, import them and sell to wholesalers, private hospitals and pharmacies in federal Iraq and Kurdistan.

    • Pioneer Co. for Pharmaceutical Industries
    • Awamedica (Awa Group)
    • Al Mansour Pharmaceutical Industries
    • Modern Drug Industries (MDI)
    • Zozik Group

    Multinational

    International logistics groups providing inbound freight, customs clearance and domestic transport for distributors and manufacturers; they do not register products.

    • DHL Global Forwarding Iraq
    • Aramex Iraq

    Regional

    MENA pharmaceutical groups from Jordan, the Gulf and Turkey that market in Iraq through appointed bureaus and their own scientific offices, often combining tender supply with branded-generics detailing.

    • MS Pharma (Iraq)
    • Hikma Pharmaceuticals (Iraq operations)
    • Julphar (Iraq)

    Wholesalers, importers & 3PL

    The federal and Kurdish state buyers and the state manufacturer whose tenders, payment cycles and formularies define the public channel and, by their gaps, the size of the private one.

    • KIMADIA (State Company for Marketing Drugs and Medical Appliances)
    • KRG Ministry of Health — Directorate of Medical Supplies
    • Samarra Drug Industries (SDI)

    What is moving

    What is moving pharma distribution in Iraq

    KIMADIA tender reform and payment normalisation

    Higher federal health budgets and efforts to clear supplier arrears are restoring KIMADIA’s credibility as a buyer, drawing multinational bidders back and squeezing the grey-market share of the private channel.

    Private hospital expansion in Baghdad, Basra and Erbil

    New private hospitals and specialty centres are creating institutional accounts that buy directly from bureaus at higher service levels than the traditional wholesale markets provide.

    Local manufacturing revival

    Pioneer, Awamedica, Al Mansour and MDI are expanding capacity and winning tender preference, prompting foreign brands to consider toll-manufacturing and licensing deals rather than pure import.

    Regulatory tightening and anti-counterfeit controls

    Stricter MOH registration, border inspection and track-and-trace pilots are raising barriers for informal importers and rewarding licensed bureaus with compliant cold-chain and documentation.

    BioNixus fieldwork

    How BioNixus studies pharmaceutical distributors in Iraq

    The accounts above are the ones our field teams and analysts work with. What a brand team typically commissions from us in Iraq:
    • Bureau and distributor due diligence: 20–40 interviews with hospital pharmacists, wholesalers and pharmacy owners across Baghdad, Basra, Mosul and Erbil on coverage, credit and cold-chain reliability.
    • KIMADIA and KRG tender landscaping: bidders, award prices, payment timing and the share of volume met by domestic manufacturers.
    • Pharmacy availability and price audits for defined molecule baskets, including grey-import and parallel-trade exposure.
    • Private hospital purchasing studies in Baghdad and Erbil covering formulary access and direct-from-bureau supply.

    Questions

    Frequently Asked Questions

    How does a foreign pharmaceutical company register a product in Iraq?

    Through a licensed Iraqi scientific bureau that submits the dossier to the federal Ministry of Health and, for the north, through a Kurdish partner filing with the KRG Ministry of Health. The bureau becomes the importer of record for the private channel, while KIMADIA supplier registration is a separate step for tenders.

    Is KIMADIA the only buyer for Iraqi public hospitals?

    For federal Ministry of Health facilities, yes. The Kurdistan Region procures separately, and some ministries and university hospitals run supplementary purchases, but KIMADIA tenders remain the single largest institutional demand source.

    Why is the private pharmacy channel so large in Iraq?

    Because public facilities have historically run short of medicines, most Iraqis buy prescriptions out of pocket at private pharmacies supplied by wholesalers in Baghdad’s drug markets and by bureaus, making the private channel the majority of value.

    Do brands need separate distributors for Kurdistan?

    Usually. The KRG registers products independently, Erbil and Sulaymaniyah distributors such as Zozik dominate northern coverage, and cross-border logistics from Turkey make the north a distinct commercial territory from Baghdad and Basra.

    What does BioNixus study about pharmaceutical distribution in Iraq?

    Bureau and distributor evaluation through interviews with hospital pharmacists, wholesalers and pharmacy owners in Baghdad, Basra and Erbil; KIMADIA and KRG tender mapping; pharmacy availability audits; and grey-import and counterfeit exposure assessments for specific molecules.

    Does this list rank Iraqi distributors?

    It does not. Organisations are grouped by function and included because they recur in BioNixus Iraq fieldwork and public registrations; the sequence carries no judgement about size or reliability.

    Sources

    Data sources & methodology

    This directory aggregates publicly available company and channel facts — filings, brand sites, and BioNixus fieldwork in Iraq. It is an editorial snapshot of the accounts we study, not a share ranking and not a substitute for NielsenIQ, IQVIA, or another syndicated feed.

    Primary register: Iraq Ministry of Health — KIMADIA supplier registration and licensed scientific bureaus, consulted 2026-09-03. Company classification (Local / MNC / Regional / wholesalers, importers & 3pl) reflects ownership and role in Iraq, not size.

    • KIMADIA tender announcements and supplier registration notices, 2024–2026
    • Kurdistan Region Ministry of Health registration and procurement updates, 2024–2025
    • World Bank and WHO Iraq health financing and out-of-pocket expenditure data, 2023–2024
    • BioNixus Iraq pharmacy, hospital and distributor fieldwork in Baghdad, Basra and Erbil, 2023–2026

    BioNixus sells account-level and SKU-level primary research that complements those subscriptions. For a scoped proposal, contact the team or use the form below. Email admin@bionixus.com.

    48-hour proposal

    Need distributor and channel data in Iraq?

    Coverage, credit terms, cold-chain capability and share of pharmacy purchases by wholesaler — from the pharmacies and hospitals themselves, not a directory.

    Planning research in Iraq?

    Primary research, market access & HEOR. A 30-minute scoping call, then a costed proposal within 48 hours.

    What happens on the call

    • We pin down the decision your research has to support.
    • We check feasibility: respondent types, countries and timeline.
    • You receive a costed proposal within 48 hours of the call.